Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Drugs Design). Showing records 1 – 30 of 95 total matches.

[1] [2] [3] [4]

Search Limiters

Last 2 Years | English Only

Country

▼ Search Limiters

1. Maram, . Sambasiva Rao. Design and Development of Oral Modified release dosage forms of Highly soluble drugs; -.

Degree: Pharmaceutical Sciences, 2013, Jawaharlal Nehru Technological University, Hyderabad

The ultimate goal of the study was to develop a stable, cost effective modified release dosage form of highly soluble drugs such as newlineTrimetazidine dihydrochloride,… (more)

Subjects/Keywords: Design; Development; Dosage; Drugs; Modified

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Maram, . S. R. (2013). Design and Development of Oral Modified release dosage forms of Highly soluble drugs; -. (Thesis). Jawaharlal Nehru Technological University, Hyderabad. Retrieved from http://shodhganga.inflibnet.ac.in/handle/10603/18958

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Maram, Sambasiva Rao. “Design and Development of Oral Modified release dosage forms of Highly soluble drugs; -.” 2013. Thesis, Jawaharlal Nehru Technological University, Hyderabad. Accessed March 19, 2019. http://shodhganga.inflibnet.ac.in/handle/10603/18958.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Maram, Sambasiva Rao. “Design and Development of Oral Modified release dosage forms of Highly soluble drugs; -.” 2013. Web. 19 Mar 2019.

Vancouver:

Maram SR. Design and Development of Oral Modified release dosage forms of Highly soluble drugs; -. [Internet] [Thesis]. Jawaharlal Nehru Technological University, Hyderabad; 2013. [cited 2019 Mar 19]. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/18958.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Maram SR. Design and Development of Oral Modified release dosage forms of Highly soluble drugs; -. [Thesis]. Jawaharlal Nehru Technological University, Hyderabad; 2013. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/18958

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

2. Gornganok Piboonpol. Effect of phenytoin on the pharmacokinetics of efavirenz in rabbits .

Degree: คณะวิทยาศาสตร์ ภาควิชาเภสัชวิทยา, 2012, Prince of Songkla University

Subjects/Keywords: Pharmacokinetics; Drugs Metabolism; Drugs Design

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Piboonpol, G. (2012). Effect of phenytoin on the pharmacokinetics of efavirenz in rabbits . (Thesis). Prince of Songkla University. Retrieved from http://kb.psu.ac.th/psukb/handle/2010/8904

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Piboonpol, Gornganok. “Effect of phenytoin on the pharmacokinetics of efavirenz in rabbits .” 2012. Thesis, Prince of Songkla University. Accessed March 19, 2019. http://kb.psu.ac.th/psukb/handle/2010/8904.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Piboonpol, Gornganok. “Effect of phenytoin on the pharmacokinetics of efavirenz in rabbits .” 2012. Web. 19 Mar 2019.

Vancouver:

Piboonpol G. Effect of phenytoin on the pharmacokinetics of efavirenz in rabbits . [Internet] [Thesis]. Prince of Songkla University; 2012. [cited 2019 Mar 19]. Available from: http://kb.psu.ac.th/psukb/handle/2010/8904.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Piboonpol G. Effect of phenytoin on the pharmacokinetics of efavirenz in rabbits . [Thesis]. Prince of Songkla University; 2012. Available from: http://kb.psu.ac.th/psukb/handle/2010/8904

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Nelson Mandela Metropolitan University

3. Isaacs, Nasreen. Formulation and process optimisation of ethionamide 250 MGtablets using quality by design principles.

Degree: Faculty of Health Sciences, 2015, Nelson Mandela Metropolitan University

 The traditional approach of Quality by Testing (QbT) limits the assurance of product quality to in-process and post-production testing. To overcome these limitations, a more… (more)

Subjects/Keywords: Pharmaceutical chemistry; Drugs  – Design; Pharmaceutical technology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Isaacs, N. (2015). Formulation and process optimisation of ethionamide 250 MGtablets using quality by design principles. (Thesis). Nelson Mandela Metropolitan University. Retrieved from http://hdl.handle.net/10948/3979

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Isaacs, Nasreen. “Formulation and process optimisation of ethionamide 250 MGtablets using quality by design principles.” 2015. Thesis, Nelson Mandela Metropolitan University. Accessed March 19, 2019. http://hdl.handle.net/10948/3979.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Isaacs, Nasreen. “Formulation and process optimisation of ethionamide 250 MGtablets using quality by design principles.” 2015. Web. 19 Mar 2019.

Vancouver:

Isaacs N. Formulation and process optimisation of ethionamide 250 MGtablets using quality by design principles. [Internet] [Thesis]. Nelson Mandela Metropolitan University; 2015. [cited 2019 Mar 19]. Available from: http://hdl.handle.net/10948/3979.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Isaacs N. Formulation and process optimisation of ethionamide 250 MGtablets using quality by design principles. [Thesis]. Nelson Mandela Metropolitan University; 2015. Available from: http://hdl.handle.net/10948/3979

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Hong Kong University of Science and Technology

4. Hadiwinoto, Gabriela Daisy CBME. A proof of concept for integrated continuous manufacturing of a pharmaceutical for dry powder inhalation.

Degree: 2017, Hong Kong University of Science and Technology

 The direct administration of drugs to the pulmonary tract offers important advantages for treatment of various local and systemic diseases compared to oral administration. A… (more)

Subjects/Keywords: Drug delivery systems; Design; Drugs; Pulmonary pharmacology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hadiwinoto, G. D. C. (2017). A proof of concept for integrated continuous manufacturing of a pharmaceutical for dry powder inhalation. (Thesis). Hong Kong University of Science and Technology. Retrieved from https://doi.org/10.14711/thesis-991012551364603412 ; http://repository.ust.hk/ir/bitstream/1783.1-91124/1/th_redirect.html

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hadiwinoto, Gabriela Daisy CBME. “A proof of concept for integrated continuous manufacturing of a pharmaceutical for dry powder inhalation.” 2017. Thesis, Hong Kong University of Science and Technology. Accessed March 19, 2019. https://doi.org/10.14711/thesis-991012551364603412 ; http://repository.ust.hk/ir/bitstream/1783.1-91124/1/th_redirect.html.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hadiwinoto, Gabriela Daisy CBME. “A proof of concept for integrated continuous manufacturing of a pharmaceutical for dry powder inhalation.” 2017. Web. 19 Mar 2019.

Vancouver:

Hadiwinoto GDC. A proof of concept for integrated continuous manufacturing of a pharmaceutical for dry powder inhalation. [Internet] [Thesis]. Hong Kong University of Science and Technology; 2017. [cited 2019 Mar 19]. Available from: https://doi.org/10.14711/thesis-991012551364603412 ; http://repository.ust.hk/ir/bitstream/1783.1-91124/1/th_redirect.html.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hadiwinoto GDC. A proof of concept for integrated continuous manufacturing of a pharmaceutical for dry powder inhalation. [Thesis]. Hong Kong University of Science and Technology; 2017. Available from: https://doi.org/10.14711/thesis-991012551364603412 ; http://repository.ust.hk/ir/bitstream/1783.1-91124/1/th_redirect.html

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Texas State University – San Marcos

5. Middleton, Kelsey. Working Towards a Cancer Cell Selective and Brain Penetrating Anti Glioma Drug.

Degree: MS, Chemistry, 2016, Texas State University – San Marcos

 Glioblastoma multiforme is one of the most fatal and hardest to treat cancers. The main reasons for our failure to treat this type of cancer… (more)

Subjects/Keywords: Chemistry; Biochemistry; Drug design; Middleton; Kornienko; Cancer – Research; Drugs – Design; Biochemistry

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Middleton, K. (2016). Working Towards a Cancer Cell Selective and Brain Penetrating Anti Glioma Drug. (Masters Thesis). Texas State University – San Marcos. Retrieved from https://digital.library.txstate.edu/handle/10877/6340

Chicago Manual of Style (16th Edition):

Middleton, Kelsey. “Working Towards a Cancer Cell Selective and Brain Penetrating Anti Glioma Drug.” 2016. Masters Thesis, Texas State University – San Marcos. Accessed March 19, 2019. https://digital.library.txstate.edu/handle/10877/6340.

MLA Handbook (7th Edition):

Middleton, Kelsey. “Working Towards a Cancer Cell Selective and Brain Penetrating Anti Glioma Drug.” 2016. Web. 19 Mar 2019.

Vancouver:

Middleton K. Working Towards a Cancer Cell Selective and Brain Penetrating Anti Glioma Drug. [Internet] [Masters thesis]. Texas State University – San Marcos; 2016. [cited 2019 Mar 19]. Available from: https://digital.library.txstate.edu/handle/10877/6340.

Council of Science Editors:

Middleton K. Working Towards a Cancer Cell Selective and Brain Penetrating Anti Glioma Drug. [Masters Thesis]. Texas State University – San Marcos; 2016. Available from: https://digital.library.txstate.edu/handle/10877/6340


Virginia Commonwealth University

6. Tripathi, Ashutosh. DEVELOPMENT OF HINT BASED COMPUTATIONAL TOOLS FOR DRUG DESIGN: APPLICATIONS IN THE DESIGN AND DEVELOPMENT OF NOVEL ANTI-CANCER AGENTS.

Degree: PhD, Medicinal Chemistry, 2009, Virginia Commonwealth University

 The overall aim of the research is to develop a computational platform based on HINT paradigm for manipulating, predicting and analyzing biomacromolecular-ligand structure. A second… (more)

Subjects/Keywords: HINT; Computer Aided Drug Design; Anti-Cancer Drugs; Chemicals and Drugs; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tripathi, A. (2009). DEVELOPMENT OF HINT BASED COMPUTATIONAL TOOLS FOR DRUG DESIGN: APPLICATIONS IN THE DESIGN AND DEVELOPMENT OF NOVEL ANTI-CANCER AGENTS. (Doctoral Dissertation). Virginia Commonwealth University. Retrieved from https://scholarscompass.vcu.edu/etd/1866

Chicago Manual of Style (16th Edition):

Tripathi, Ashutosh. “DEVELOPMENT OF HINT BASED COMPUTATIONAL TOOLS FOR DRUG DESIGN: APPLICATIONS IN THE DESIGN AND DEVELOPMENT OF NOVEL ANTI-CANCER AGENTS.” 2009. Doctoral Dissertation, Virginia Commonwealth University. Accessed March 19, 2019. https://scholarscompass.vcu.edu/etd/1866.

MLA Handbook (7th Edition):

Tripathi, Ashutosh. “DEVELOPMENT OF HINT BASED COMPUTATIONAL TOOLS FOR DRUG DESIGN: APPLICATIONS IN THE DESIGN AND DEVELOPMENT OF NOVEL ANTI-CANCER AGENTS.” 2009. Web. 19 Mar 2019.

Vancouver:

Tripathi A. DEVELOPMENT OF HINT BASED COMPUTATIONAL TOOLS FOR DRUG DESIGN: APPLICATIONS IN THE DESIGN AND DEVELOPMENT OF NOVEL ANTI-CANCER AGENTS. [Internet] [Doctoral dissertation]. Virginia Commonwealth University; 2009. [cited 2019 Mar 19]. Available from: https://scholarscompass.vcu.edu/etd/1866.

Council of Science Editors:

Tripathi A. DEVELOPMENT OF HINT BASED COMPUTATIONAL TOOLS FOR DRUG DESIGN: APPLICATIONS IN THE DESIGN AND DEVELOPMENT OF NOVEL ANTI-CANCER AGENTS. [Doctoral Dissertation]. Virginia Commonwealth University; 2009. Available from: https://scholarscompass.vcu.edu/etd/1866

7. Nargotra, Amit. Structure prediction and molecular modeling analysis of therapeutically important targets using in silico approach.

Degree: Bioinformatics, 2010, Jamia Hamdard University

newline

References p. 177-202

Advisors/Committee Members: Hirwani, R R.

Subjects/Keywords: Drugs-Design; Drugs-Structure-activity relationship

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nargotra, A. (2010). Structure prediction and molecular modeling analysis of therapeutically important targets using in silico approach. (Thesis). Jamia Hamdard University. Retrieved from http://shodhganga.inflibnet.ac.in/handle/10603/14581

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Nargotra, Amit. “Structure prediction and molecular modeling analysis of therapeutically important targets using in silico approach.” 2010. Thesis, Jamia Hamdard University. Accessed March 19, 2019. http://shodhganga.inflibnet.ac.in/handle/10603/14581.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Nargotra, Amit. “Structure prediction and molecular modeling analysis of therapeutically important targets using in silico approach.” 2010. Web. 19 Mar 2019.

Vancouver:

Nargotra A. Structure prediction and molecular modeling analysis of therapeutically important targets using in silico approach. [Internet] [Thesis]. Jamia Hamdard University; 2010. [cited 2019 Mar 19]. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/14581.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Nargotra A. Structure prediction and molecular modeling analysis of therapeutically important targets using in silico approach. [Thesis]. Jamia Hamdard University; 2010. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/14581

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

8. Dadrwal, Subhash Chand. Design and evaluation of chrono pharmaceutical drug delivery systems of antihypertensive drugs; -.

Degree: Pharmacy, 2012, University of Delhi

Available

Bibliography given

Advisors/Committee Members: Agrawal, S S.

Subjects/Keywords: antihypertensive drugs; chrono pharmaceutical; Design

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dadrwal, S. C. (2012). Design and evaluation of chrono pharmaceutical drug delivery systems of antihypertensive drugs; -. (Thesis). University of Delhi. Retrieved from http://shodhganga.inflibnet.ac.in/handle/10603/31486

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Dadrwal, Subhash Chand. “Design and evaluation of chrono pharmaceutical drug delivery systems of antihypertensive drugs; -.” 2012. Thesis, University of Delhi. Accessed March 19, 2019. http://shodhganga.inflibnet.ac.in/handle/10603/31486.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Dadrwal, Subhash Chand. “Design and evaluation of chrono pharmaceutical drug delivery systems of antihypertensive drugs; -.” 2012. Web. 19 Mar 2019.

Vancouver:

Dadrwal SC. Design and evaluation of chrono pharmaceutical drug delivery systems of antihypertensive drugs; -. [Internet] [Thesis]. University of Delhi; 2012. [cited 2019 Mar 19]. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/31486.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Dadrwal SC. Design and evaluation of chrono pharmaceutical drug delivery systems of antihypertensive drugs; -. [Thesis]. University of Delhi; 2012. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/31486

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Toronto

9. Lugtu-Pe, Jamie Anne. Controlled Release as a Strategy to Prevent Solution-mediated Phase Transformation in Amorphous Solid Dispersions: Effect of Dosage Form Design.

Degree: 2014, University of Toronto

The purpose of this study was to define the limits of developing a controlled-release amorphous solid dispersion (CRSD) system intended for enhancing the bioavailability of… (more)

Subjects/Keywords: controlled release; dosage form design; poorly soluble drugs; solid dispersion; 0572

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lugtu-Pe, J. A. (2014). Controlled Release as a Strategy to Prevent Solution-mediated Phase Transformation in Amorphous Solid Dispersions: Effect of Dosage Form Design. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/81085

Chicago Manual of Style (16th Edition):

Lugtu-Pe, Jamie Anne. “Controlled Release as a Strategy to Prevent Solution-mediated Phase Transformation in Amorphous Solid Dispersions: Effect of Dosage Form Design.” 2014. Masters Thesis, University of Toronto. Accessed March 19, 2019. http://hdl.handle.net/1807/81085.

MLA Handbook (7th Edition):

Lugtu-Pe, Jamie Anne. “Controlled Release as a Strategy to Prevent Solution-mediated Phase Transformation in Amorphous Solid Dispersions: Effect of Dosage Form Design.” 2014. Web. 19 Mar 2019.

Vancouver:

Lugtu-Pe JA. Controlled Release as a Strategy to Prevent Solution-mediated Phase Transformation in Amorphous Solid Dispersions: Effect of Dosage Form Design. [Internet] [Masters thesis]. University of Toronto; 2014. [cited 2019 Mar 19]. Available from: http://hdl.handle.net/1807/81085.

Council of Science Editors:

Lugtu-Pe JA. Controlled Release as a Strategy to Prevent Solution-mediated Phase Transformation in Amorphous Solid Dispersions: Effect of Dosage Form Design. [Masters Thesis]. University of Toronto; 2014. Available from: http://hdl.handle.net/1807/81085


University of Toronto

10. Lugtu-Pe, Jamie Anne. Controlled Release as a Strategy to Prevent Solution-mediated Phase Transformation in Amorphous Solid Dispersions: Effect of Dosage Form Design.

Degree: 2014, University of Toronto

The purpose of this study was to define the limits of developing a controlled-release amorphous solid dispersion (CRSD) system intended for enhancing the bioavailability of… (more)

Subjects/Keywords: controlled release; dosage form design; poorly soluble drugs; solid dispersion; 0572

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lugtu-Pe, J. A. (2014). Controlled Release as a Strategy to Prevent Solution-mediated Phase Transformation in Amorphous Solid Dispersions: Effect of Dosage Form Design. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/81086

Chicago Manual of Style (16th Edition):

Lugtu-Pe, Jamie Anne. “Controlled Release as a Strategy to Prevent Solution-mediated Phase Transformation in Amorphous Solid Dispersions: Effect of Dosage Form Design.” 2014. Masters Thesis, University of Toronto. Accessed March 19, 2019. http://hdl.handle.net/1807/81086.

MLA Handbook (7th Edition):

Lugtu-Pe, Jamie Anne. “Controlled Release as a Strategy to Prevent Solution-mediated Phase Transformation in Amorphous Solid Dispersions: Effect of Dosage Form Design.” 2014. Web. 19 Mar 2019.

Vancouver:

Lugtu-Pe JA. Controlled Release as a Strategy to Prevent Solution-mediated Phase Transformation in Amorphous Solid Dispersions: Effect of Dosage Form Design. [Internet] [Masters thesis]. University of Toronto; 2014. [cited 2019 Mar 19]. Available from: http://hdl.handle.net/1807/81086.

Council of Science Editors:

Lugtu-Pe JA. Controlled Release as a Strategy to Prevent Solution-mediated Phase Transformation in Amorphous Solid Dispersions: Effect of Dosage Form Design. [Masters Thesis]. University of Toronto; 2014. Available from: http://hdl.handle.net/1807/81086


Hong Kong University of Science and Technology

11. Gu, Shuo. Computational exploration of protein ligand interaction and its applications in drug discovery.

Degree: 2015, Hong Kong University of Science and Technology

 My PhD research can be summarized as two major directions. One direction is the theoretical investigation of protein conformational dynamics. In particular, we have developed… (more)

Subjects/Keywords: Protein-protein interactions; Computer simulation; Ligand binding (Biochemistry); Drugs; Design

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gu, S. (2015). Computational exploration of protein ligand interaction and its applications in drug discovery. (Thesis). Hong Kong University of Science and Technology. Retrieved from https://doi.org/10.14711/thesis-b1514980 ; http://repository.ust.hk/ir/bitstream/1783.1-80261/1/th_redirect.html

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Gu, Shuo. “Computational exploration of protein ligand interaction and its applications in drug discovery.” 2015. Thesis, Hong Kong University of Science and Technology. Accessed March 19, 2019. https://doi.org/10.14711/thesis-b1514980 ; http://repository.ust.hk/ir/bitstream/1783.1-80261/1/th_redirect.html.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Gu, Shuo. “Computational exploration of protein ligand interaction and its applications in drug discovery.” 2015. Web. 19 Mar 2019.

Vancouver:

Gu S. Computational exploration of protein ligand interaction and its applications in drug discovery. [Internet] [Thesis]. Hong Kong University of Science and Technology; 2015. [cited 2019 Mar 19]. Available from: https://doi.org/10.14711/thesis-b1514980 ; http://repository.ust.hk/ir/bitstream/1783.1-80261/1/th_redirect.html.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Gu S. Computational exploration of protein ligand interaction and its applications in drug discovery. [Thesis]. Hong Kong University of Science and Technology; 2015. Available from: https://doi.org/10.14711/thesis-b1514980 ; http://repository.ust.hk/ir/bitstream/1783.1-80261/1/th_redirect.html

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Hong Kong

12. 施昀; Shi, Yun. Escalation with overdose control for phase I drug-combination trials.

Degree: M. Phil., 2013, University of Hong Kong

The escalation with overdose control (EWOC) method is a popular modelbased dose finding design for phase I clinical trials. Dose finding for combined drugs has… (more)

Subjects/Keywords: Clinical trials - Statistical methods.; Drug development.; Drugs - Design.; Pharmaceutical arithmetic.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

施昀; Shi, Y. (2013). Escalation with overdose control for phase I drug-combination trials. (Masters Thesis). University of Hong Kong. Retrieved from Shi, Y. [施昀]. (2013). Escalation with overdose control for phase I drug-combination trials. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b4979973 ; http://dx.doi.org/10.5353/th_b4979973 ; http://hdl.handle.net/10722/181539

Chicago Manual of Style (16th Edition):

施昀; Shi, Yun. “Escalation with overdose control for phase I drug-combination trials.” 2013. Masters Thesis, University of Hong Kong. Accessed March 19, 2019. Shi, Y. [施昀]. (2013). Escalation with overdose control for phase I drug-combination trials. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b4979973 ; http://dx.doi.org/10.5353/th_b4979973 ; http://hdl.handle.net/10722/181539.

MLA Handbook (7th Edition):

施昀; Shi, Yun. “Escalation with overdose control for phase I drug-combination trials.” 2013. Web. 19 Mar 2019.

Vancouver:

施昀; Shi Y. Escalation with overdose control for phase I drug-combination trials. [Internet] [Masters thesis]. University of Hong Kong; 2013. [cited 2019 Mar 19]. Available from: Shi, Y. [施昀]. (2013). Escalation with overdose control for phase I drug-combination trials. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b4979973 ; http://dx.doi.org/10.5353/th_b4979973 ; http://hdl.handle.net/10722/181539.

Council of Science Editors:

施昀; Shi Y. Escalation with overdose control for phase I drug-combination trials. [Masters Thesis]. University of Hong Kong; 2013. Available from: Shi, Y. [施昀]. (2013). Escalation with overdose control for phase I drug-combination trials. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b4979973 ; http://dx.doi.org/10.5353/th_b4979973 ; http://hdl.handle.net/10722/181539


Ryerson University

13. Khan, Anessa. Towards Smart Drug Delivery: Exploration Of A Molecularly Imprinted Polymer Network.

Degree: 2012, Ryerson University

 The current study explores the concept of Molecular Imprinting Technology (MIT) and evaluates the ability of a molecularly imprinted hydrogel polymer (MIP) to preferentially uptake… (more)

Subjects/Keywords: Drug delivery systems  – Technological innovations; Smart materials; Drugs  – Design

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Khan, A. (2012). Towards Smart Drug Delivery: Exploration Of A Molecularly Imprinted Polymer Network. (Thesis). Ryerson University. Retrieved from https://digital.library.ryerson.ca/islandora/object/RULA%3A2239

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Khan, Anessa. “Towards Smart Drug Delivery: Exploration Of A Molecularly Imprinted Polymer Network.” 2012. Thesis, Ryerson University. Accessed March 19, 2019. https://digital.library.ryerson.ca/islandora/object/RULA%3A2239.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Khan, Anessa. “Towards Smart Drug Delivery: Exploration Of A Molecularly Imprinted Polymer Network.” 2012. Web. 19 Mar 2019.

Vancouver:

Khan A. Towards Smart Drug Delivery: Exploration Of A Molecularly Imprinted Polymer Network. [Internet] [Thesis]. Ryerson University; 2012. [cited 2019 Mar 19]. Available from: https://digital.library.ryerson.ca/islandora/object/RULA%3A2239.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Khan A. Towards Smart Drug Delivery: Exploration Of A Molecularly Imprinted Polymer Network. [Thesis]. Ryerson University; 2012. Available from: https://digital.library.ryerson.ca/islandora/object/RULA%3A2239

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Ryerson University

14. Elmallah, Salma. Progress Toward The Synthesis Of Labeled Derivatives Of The Cystic Fibrosis Drug Ivacaftor.

Degree: 2012, Ryerson University

 Cystic fibrosis (CF) is one of the most common genetic diseases, affecting approximately 70,000 people worldwide causing severe complications and often leading to early death.… (more)

Subjects/Keywords: Cystic fibrosis  – Pathophysiology; Cystic fibrosis  – Treatment; Drugs  – Design; Pharmaceutical chemistry

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Elmallah, S. (2012). Progress Toward The Synthesis Of Labeled Derivatives Of The Cystic Fibrosis Drug Ivacaftor. (Thesis). Ryerson University. Retrieved from https://digital.library.ryerson.ca/islandora/object/RULA%3A1478

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Elmallah, Salma. “Progress Toward The Synthesis Of Labeled Derivatives Of The Cystic Fibrosis Drug Ivacaftor.” 2012. Thesis, Ryerson University. Accessed March 19, 2019. https://digital.library.ryerson.ca/islandora/object/RULA%3A1478.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Elmallah, Salma. “Progress Toward The Synthesis Of Labeled Derivatives Of The Cystic Fibrosis Drug Ivacaftor.” 2012. Web. 19 Mar 2019.

Vancouver:

Elmallah S. Progress Toward The Synthesis Of Labeled Derivatives Of The Cystic Fibrosis Drug Ivacaftor. [Internet] [Thesis]. Ryerson University; 2012. [cited 2019 Mar 19]. Available from: https://digital.library.ryerson.ca/islandora/object/RULA%3A1478.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Elmallah S. Progress Toward The Synthesis Of Labeled Derivatives Of The Cystic Fibrosis Drug Ivacaftor. [Thesis]. Ryerson University; 2012. Available from: https://digital.library.ryerson.ca/islandora/object/RULA%3A1478

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of St Andrews

15. Rogers, Graeme W. The development of sialidase inhibitors using structure-based drug design.

Degree: PhD, 2017, University of St Andrews

 The sialidases/neuraminidases represent a family of enzymes whose function is important in the pathogenicity of bacteria and the virulence of influenza. Relenza and Tamiflu represent… (more)

Subjects/Keywords: QP609.N48R7; Neutral proteinases; Drugs – Design; Neuraminidase – Inhibitors; Enzyme inhibitors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rogers, G. W. (2017). The development of sialidase inhibitors using structure-based drug design. (Doctoral Dissertation). University of St Andrews. Retrieved from http://hdl.handle.net/10023/15516

Chicago Manual of Style (16th Edition):

Rogers, Graeme W. “The development of sialidase inhibitors using structure-based drug design.” 2017. Doctoral Dissertation, University of St Andrews. Accessed March 19, 2019. http://hdl.handle.net/10023/15516.

MLA Handbook (7th Edition):

Rogers, Graeme W. “The development of sialidase inhibitors using structure-based drug design.” 2017. Web. 19 Mar 2019.

Vancouver:

Rogers GW. The development of sialidase inhibitors using structure-based drug design. [Internet] [Doctoral dissertation]. University of St Andrews; 2017. [cited 2019 Mar 19]. Available from: http://hdl.handle.net/10023/15516.

Council of Science Editors:

Rogers GW. The development of sialidase inhibitors using structure-based drug design. [Doctoral Dissertation]. University of St Andrews; 2017. Available from: http://hdl.handle.net/10023/15516


Tartu University

16. Semjonov, Kristian. Development of pharmaceutical quench-cooled molten and melt-electrospun solid dispersions for poorly water-soluble indomethacin .

Degree: 2018, Tartu University

 Kirjanduse andmetel 40% turustatud ja 75% väljatöötamise või tootmise faasis olevatest raviainetest klassifitseeritakse vees halvasti lahustuvateks. Uudsed ravimvormide disaini ja valmistamise strateegiad, abiained ja tootmisemeetodid… (more)

Subjects/Keywords: drug design; indomethacin; solubility; solid drugs; pharmaceutical technology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Semjonov, K. (2018). Development of pharmaceutical quench-cooled molten and melt-electrospun solid dispersions for poorly water-soluble indomethacin . (Thesis). Tartu University. Retrieved from http://hdl.handle.net/10062/62137

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Semjonov, Kristian. “Development of pharmaceutical quench-cooled molten and melt-electrospun solid dispersions for poorly water-soluble indomethacin .” 2018. Thesis, Tartu University. Accessed March 19, 2019. http://hdl.handle.net/10062/62137.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Semjonov, Kristian. “Development of pharmaceutical quench-cooled molten and melt-electrospun solid dispersions for poorly water-soluble indomethacin .” 2018. Web. 19 Mar 2019.

Vancouver:

Semjonov K. Development of pharmaceutical quench-cooled molten and melt-electrospun solid dispersions for poorly water-soluble indomethacin . [Internet] [Thesis]. Tartu University; 2018. [cited 2019 Mar 19]. Available from: http://hdl.handle.net/10062/62137.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Semjonov K. Development of pharmaceutical quench-cooled molten and melt-electrospun solid dispersions for poorly water-soluble indomethacin . [Thesis]. Tartu University; 2018. Available from: http://hdl.handle.net/10062/62137

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

17. Karlsson, Ida. Du är inte ensam : Hur en kommun kan använda sig av retorik och berättarteknik i informationsmarterial för att nå ut till barn och ungdomar i utsatta miljöer.

Degree: Design and Engineering, 2019, Mälardalen University

In Sweden there are about 385,000 children and adolescents living with one or two parents who abuse alcohol. All over the country there is several… (more)

Subjects/Keywords: Information design; text design; rhetoric; narrative; alcohol; drugs; Informationsdesign; textdesign; retorik; berättarteknik; alkohol; droger; utsatt målgrupp; Design; Design

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Karlsson, I. (2019). Du är inte ensam : Hur en kommun kan använda sig av retorik och berättarteknik i informationsmarterial för att nå ut till barn och ungdomar i utsatta miljöer. (Thesis). Mälardalen University. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:mdh:diva-42593

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Karlsson, Ida. “Du är inte ensam : Hur en kommun kan använda sig av retorik och berättarteknik i informationsmarterial för att nå ut till barn och ungdomar i utsatta miljöer.” 2019. Thesis, Mälardalen University. Accessed March 19, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:mdh:diva-42593.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Karlsson, Ida. “Du är inte ensam : Hur en kommun kan använda sig av retorik och berättarteknik i informationsmarterial för att nå ut till barn och ungdomar i utsatta miljöer.” 2019. Web. 19 Mar 2019.

Vancouver:

Karlsson I. Du är inte ensam : Hur en kommun kan använda sig av retorik och berättarteknik i informationsmarterial för att nå ut till barn och ungdomar i utsatta miljöer. [Internet] [Thesis]. Mälardalen University; 2019. [cited 2019 Mar 19]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:mdh:diva-42593.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Karlsson I. Du är inte ensam : Hur en kommun kan använda sig av retorik och berättarteknik i informationsmarterial för att nå ut till barn och ungdomar i utsatta miljöer. [Thesis]. Mälardalen University; 2019. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:mdh:diva-42593

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Rhodes University

18. Chaibva, Faith Anesu. The use of response surface methodology and artificial neural networks for the establishment of a design space for a sustained release salbutamol sulphate formulation.

Degree: Faculty of Pharmacy, Pharmacy, 2010, Rhodes University

 Quality by Design (QbD) is a systematic approach that has been recommended as suitable for the development of quality pharmaceutical products. The QbD approach commences… (more)

Subjects/Keywords: Salbutamol sulphate; Artificial intelligence  – Medical applications; Neural networks (Computer science); Response surfaces (Statistics); Pharmaceutical biotechnology  – Quality contro; Drugs  – Design; Pharmacokinetics; Drugs  – Dosage forms; Drugs  – Controlled release

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chaibva, F. A. (2010). The use of response surface methodology and artificial neural networks for the establishment of a design space for a sustained release salbutamol sulphate formulation. (Thesis). Rhodes University. Retrieved from http://hdl.handle.net/10962/d1010432

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chaibva, Faith Anesu. “The use of response surface methodology and artificial neural networks for the establishment of a design space for a sustained release salbutamol sulphate formulation.” 2010. Thesis, Rhodes University. Accessed March 19, 2019. http://hdl.handle.net/10962/d1010432.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chaibva, Faith Anesu. “The use of response surface methodology and artificial neural networks for the establishment of a design space for a sustained release salbutamol sulphate formulation.” 2010. Web. 19 Mar 2019.

Vancouver:

Chaibva FA. The use of response surface methodology and artificial neural networks for the establishment of a design space for a sustained release salbutamol sulphate formulation. [Internet] [Thesis]. Rhodes University; 2010. [cited 2019 Mar 19]. Available from: http://hdl.handle.net/10962/d1010432.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chaibva FA. The use of response surface methodology and artificial neural networks for the establishment of a design space for a sustained release salbutamol sulphate formulation. [Thesis]. Rhodes University; 2010. Available from: http://hdl.handle.net/10962/d1010432

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Wayne State University

19. Yang, Ninee Shoua. The effect of changes in drug benefit design among individuals with diabetes in large employer-sponsored insurance plans.

Degree: PhD, Economics, 2011, Wayne State University

  THE EFFECT OF CHANGES IN DRUG BENEFIT DESIGN AMONG INDIVIDUALS WITH DIABETES IN LARGE EMPLOYER-SPONSORED INSURANCE PLANS By NINEE SHOUA YANG August 2011 Advisor:… (more)

Subjects/Keywords: cost-sharing; cost-shifting; diabetes; health benefit design; health care economics; prescription drugs; Economics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yang, N. S. (2011). The effect of changes in drug benefit design among individuals with diabetes in large employer-sponsored insurance plans. (Doctoral Dissertation). Wayne State University. Retrieved from https://digitalcommons.wayne.edu/oa_dissertations/339

Chicago Manual of Style (16th Edition):

Yang, Ninee Shoua. “The effect of changes in drug benefit design among individuals with diabetes in large employer-sponsored insurance plans.” 2011. Doctoral Dissertation, Wayne State University. Accessed March 19, 2019. https://digitalcommons.wayne.edu/oa_dissertations/339.

MLA Handbook (7th Edition):

Yang, Ninee Shoua. “The effect of changes in drug benefit design among individuals with diabetes in large employer-sponsored insurance plans.” 2011. Web. 19 Mar 2019.

Vancouver:

Yang NS. The effect of changes in drug benefit design among individuals with diabetes in large employer-sponsored insurance plans. [Internet] [Doctoral dissertation]. Wayne State University; 2011. [cited 2019 Mar 19]. Available from: https://digitalcommons.wayne.edu/oa_dissertations/339.

Council of Science Editors:

Yang NS. The effect of changes in drug benefit design among individuals with diabetes in large employer-sponsored insurance plans. [Doctoral Dissertation]. Wayne State University; 2011. Available from: https://digitalcommons.wayne.edu/oa_dissertations/339


Florida Atlantic University

20. Santos, Radleigh G. A novel optimization algorithm and other techniques in medicinal chemistry.

Degree: PhD, 2012, Florida Atlantic University

Summary: In this dissertation we will present a stochastic optimization algorithm and use it and other mathematical techniques to tackle problems arising in medicinal chemistry.… (more)

Subjects/Keywords: Drugs – Design – Mathematical models; Combinatorial optimization; Combinatorial chemistry; Genetic algorithms; Mathematical optimization; Stochastic processes

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Santos, R. G. (2012). A novel optimization algorithm and other techniques in medicinal chemistry. (Doctoral Dissertation). Florida Atlantic University. Retrieved from http://purl.flvc.org/FAU/3352830

Chicago Manual of Style (16th Edition):

Santos, Radleigh G. “A novel optimization algorithm and other techniques in medicinal chemistry.” 2012. Doctoral Dissertation, Florida Atlantic University. Accessed March 19, 2019. http://purl.flvc.org/FAU/3352830.

MLA Handbook (7th Edition):

Santos, Radleigh G. “A novel optimization algorithm and other techniques in medicinal chemistry.” 2012. Web. 19 Mar 2019.

Vancouver:

Santos RG. A novel optimization algorithm and other techniques in medicinal chemistry. [Internet] [Doctoral dissertation]. Florida Atlantic University; 2012. [cited 2019 Mar 19]. Available from: http://purl.flvc.org/FAU/3352830.

Council of Science Editors:

Santos RG. A novel optimization algorithm and other techniques in medicinal chemistry. [Doctoral Dissertation]. Florida Atlantic University; 2012. Available from: http://purl.flvc.org/FAU/3352830

21. Miller, David J. New methods in computational systems biology.

Degree: 2008, Drexel University

Systems biology strives to reach greater understanding of biological function through an integrative, multidisciplinary approach utilizing experimentation, theory, and simulation in equal measures. Drawing from… (more)

Subjects/Keywords: Physics; Biological systems; Drugs – Design

…map to ERK. Drugs targeting ERK require a lower concentration and have a similar binding… …bottom right are better performing than those on the top left as drugs targeting these species… …step, right axis) MAPK pathways to drugs targeting GEF. The left axis corresponds to the… …MAPK pathways to drugs targeting Gαβγ , the GDP-bound G protein trimer. The left axis… …axis) and mutated (stair step, right axis) MAPK pathways to drugs targeting… 

Page 1 Page 2 Page 3 Page 4 Page 5

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Miller, D. J. (2008). New methods in computational systems biology. (Thesis). Drexel University. Retrieved from http://hdl.handle.net/1860/2810

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Miller, David J. “New methods in computational systems biology.” 2008. Thesis, Drexel University. Accessed March 19, 2019. http://hdl.handle.net/1860/2810.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Miller, David J. “New methods in computational systems biology.” 2008. Web. 19 Mar 2019.

Vancouver:

Miller DJ. New methods in computational systems biology. [Internet] [Thesis]. Drexel University; 2008. [cited 2019 Mar 19]. Available from: http://hdl.handle.net/1860/2810.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Miller DJ. New methods in computational systems biology. [Thesis]. Drexel University; 2008. Available from: http://hdl.handle.net/1860/2810

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of the Western Cape

22. Ma, Haiqiu. The formulation, manufacture and evaluation of capsules containing freeze-dried aqueous extracts of Leonotis Leonorus or Mentha Longifolia .

Degree: 2006, University of the Western Cape

 Leonotis leonorus and Mentha longifolia are two herbs commonly used in South Africa, mostly in oral liquid dosage forms. Several disadvantages are associated with these… (more)

Subjects/Keywords: Pharmaceutical chemistry; Drug design; Drugs; Design; Materia medica; Vegetable

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ma, H. (2006). The formulation, manufacture and evaluation of capsules containing freeze-dried aqueous extracts of Leonotis Leonorus or Mentha Longifolia . (Thesis). University of the Western Cape. Retrieved from http://hdl.handle.net/11394/1925

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ma, Haiqiu. “The formulation, manufacture and evaluation of capsules containing freeze-dried aqueous extracts of Leonotis Leonorus or Mentha Longifolia .” 2006. Thesis, University of the Western Cape. Accessed March 19, 2019. http://hdl.handle.net/11394/1925.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ma, Haiqiu. “The formulation, manufacture and evaluation of capsules containing freeze-dried aqueous extracts of Leonotis Leonorus or Mentha Longifolia .” 2006. Web. 19 Mar 2019.

Vancouver:

Ma H. The formulation, manufacture and evaluation of capsules containing freeze-dried aqueous extracts of Leonotis Leonorus or Mentha Longifolia . [Internet] [Thesis]. University of the Western Cape; 2006. [cited 2019 Mar 19]. Available from: http://hdl.handle.net/11394/1925.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ma H. The formulation, manufacture and evaluation of capsules containing freeze-dried aqueous extracts of Leonotis Leonorus or Mentha Longifolia . [Thesis]. University of the Western Cape; 2006. Available from: http://hdl.handle.net/11394/1925

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Deakin University

23. Lloyd, Edward John. A common structural basis for central nervous system drug design.

Degree: 1986, Deakin University

 The main theme of this thesis is that there is a common structural basis for drugs acting on the central nervous system (CNS), and that… (more)

Subjects/Keywords: drugs; design; central nervous system; effect of drugs; structure-activity relationships; psychotropic drugs; CNS drugs; central nervous system

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lloyd, E. J. (1986). A common structural basis for central nervous system drug design. (Thesis). Deakin University. Retrieved from http://tux.lib.deakin.edu.au./adt-VDU/public/adt-VDU20050902.115505

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lloyd, Edward John. “A common structural basis for central nervous system drug design.” 1986. Thesis, Deakin University. Accessed March 19, 2019. http://tux.lib.deakin.edu.au./adt-VDU/public/adt-VDU20050902.115505.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lloyd, Edward John. “A common structural basis for central nervous system drug design.” 1986. Web. 19 Mar 2019.

Vancouver:

Lloyd EJ. A common structural basis for central nervous system drug design. [Internet] [Thesis]. Deakin University; 1986. [cited 2019 Mar 19]. Available from: http://tux.lib.deakin.edu.au./adt-VDU/public/adt-VDU20050902.115505.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lloyd EJ. A common structural basis for central nervous system drug design. [Thesis]. Deakin University; 1986. Available from: http://tux.lib.deakin.edu.au./adt-VDU/public/adt-VDU20050902.115505

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Deakin University

24. Lloyd, Edward John. Common structural basis for central nervous system drug design.

Degree: School of Sciences, 1986, Deakin University

 The main theme of this thesis is that there is a common structural basis for drugs acting on the central nervous system (CNS), and that… (more)

Subjects/Keywords: Drugs - Design; Central nervous system - Effect of drugs on; Drugs - Structure-activity relationships; Psychotropic drugs

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lloyd, E. J. (1986). Common structural basis for central nervous system drug design. (Thesis). Deakin University. Retrieved from http://hdl.handle.net/10536/DRO/DU:30023495

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lloyd, Edward John. “Common structural basis for central nervous system drug design.” 1986. Thesis, Deakin University. Accessed March 19, 2019. http://hdl.handle.net/10536/DRO/DU:30023495.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lloyd, Edward John. “Common structural basis for central nervous system drug design.” 1986. Web. 19 Mar 2019.

Vancouver:

Lloyd EJ. Common structural basis for central nervous system drug design. [Internet] [Thesis]. Deakin University; 1986. [cited 2019 Mar 19]. Available from: http://hdl.handle.net/10536/DRO/DU:30023495.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lloyd EJ. Common structural basis for central nervous system drug design. [Thesis]. Deakin University; 1986. Available from: http://hdl.handle.net/10536/DRO/DU:30023495

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas – Austin

25. Overhoff, Kirk Alan. Improved oral bioavailability of poorly water soluble drugs using rapid freezing processes.

Degree: Pharmacy, 2006, University of Texas – Austin

 A growing number of therapeutic compounds currently being developed by pharmaceutical companies are poorly water soluble leading to limited and/or erratic bioavailability. The rate limiting… (more)

Subjects/Keywords: Frozen drugs; Polymeric drug delivery systems; FK-506 (Drug) – Design; Polymeric drugs – Development; Drug development; Drugs – Solubility; Drugs – Bioavailability; Nanoparticles

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Overhoff, K. A. (2006). Improved oral bioavailability of poorly water soluble drugs using rapid freezing processes. (Thesis). University of Texas – Austin. Retrieved from http://hdl.handle.net/2152/13125

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Overhoff, Kirk Alan. “Improved oral bioavailability of poorly water soluble drugs using rapid freezing processes.” 2006. Thesis, University of Texas – Austin. Accessed March 19, 2019. http://hdl.handle.net/2152/13125.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Overhoff, Kirk Alan. “Improved oral bioavailability of poorly water soluble drugs using rapid freezing processes.” 2006. Web. 19 Mar 2019.

Vancouver:

Overhoff KA. Improved oral bioavailability of poorly water soluble drugs using rapid freezing processes. [Internet] [Thesis]. University of Texas – Austin; 2006. [cited 2019 Mar 19]. Available from: http://hdl.handle.net/2152/13125.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Overhoff KA. Improved oral bioavailability of poorly water soluble drugs using rapid freezing processes. [Thesis]. University of Texas – Austin; 2006. Available from: http://hdl.handle.net/2152/13125

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


IUPUI

26. Li, Claire. Modeling and simulation applications with potential impact in drug development and patient care.

Degree: 2014, IUPUI

Indiana University-Purdue University Indianapolis (IUPUI)

Model-based drug development has become an essential element to potentially make drug development more productive by assessing the data using… (more)

Subjects/Keywords: modeling and simulation; pharmacokinetics; pharmacodynamics; genetics; Molecular pharmacology  – Research  – Evaluation  – Methodology; Drug development  – Pharmacokinetics; Drug development  – Molecular genetics; Drugs  – Physiological effect  – Mathematical models; Simulation methods  – Research  – Evaluation  – Methodology; Mathematical models  – Research  – Evaluation  – Methodology; Drugs  – Metabolism; Drugs  – Design; Clinical trials  – Research  – Evaluation; Drugs  – Testing; Drugs  – Toxicology; Patient-centered health care; Pharmacokinetics  – Research

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Li, C. (2014). Modeling and simulation applications with potential impact in drug development and patient care. (Thesis). IUPUI. Retrieved from http://hdl.handle.net/1805/5969

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Li, Claire. “Modeling and simulation applications with potential impact in drug development and patient care.” 2014. Thesis, IUPUI. Accessed March 19, 2019. http://hdl.handle.net/1805/5969.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Li, Claire. “Modeling and simulation applications with potential impact in drug development and patient care.” 2014. Web. 19 Mar 2019.

Vancouver:

Li C. Modeling and simulation applications with potential impact in drug development and patient care. [Internet] [Thesis]. IUPUI; 2014. [cited 2019 Mar 19]. Available from: http://hdl.handle.net/1805/5969.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Li C. Modeling and simulation applications with potential impact in drug development and patient care. [Thesis]. IUPUI; 2014. Available from: http://hdl.handle.net/1805/5969

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Tartu University

27. Palo, Mirja. Design and development of personalized dosage forms by printing technology .

Degree: 2017, Tartu University

 Uurimistöö keskendus personaliseeritud ravimvormide valmistamisele kahemõõtmelise printimise abil. Personaliseeritud meditsiin arvestab patsiendi füsioloogiliste, ealiste ja käitumuslike eripäradega. Printimistehnoloogia abil saab valmistada personaliseeritud ravimvorme väikestes kogustes… (more)

Subjects/Keywords: ravimid; ravimiannused; printimine; individuaalsus; tehnoloogia; meditsiinitehnoloogia; haiged; ravimidisain; farmatseutiline tehnoloogia; drugs; drug design; dosages of drugs; printing; individuality; ill persons; pharmaceutical technology; technology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Palo, M. (2017). Design and development of personalized dosage forms by printing technology . (Thesis). Tartu University. Retrieved from http://hdl.handle.net/10062/56409

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Palo, Mirja. “Design and development of personalized dosage forms by printing technology .” 2017. Thesis, Tartu University. Accessed March 19, 2019. http://hdl.handle.net/10062/56409.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Palo, Mirja. “Design and development of personalized dosage forms by printing technology .” 2017. Web. 19 Mar 2019.

Vancouver:

Palo M. Design and development of personalized dosage forms by printing technology . [Internet] [Thesis]. Tartu University; 2017. [cited 2019 Mar 19]. Available from: http://hdl.handle.net/10062/56409.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Palo M. Design and development of personalized dosage forms by printing technology . [Thesis]. Tartu University; 2017. Available from: http://hdl.handle.net/10062/56409

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Northeastern University

28. Doxsee, Ian. The design and synthesis of novel aromatic analogues of cerulenin.

Degree: MS, Department of Chemistry and Chemical Biology, 2016, Northeastern University

 Fatty-acid synthase (FAS) is an enzyme that is important to mammalian survival but is critical to cell proliferation in many breast and prostate cancers. In… (more)

Subjects/Keywords: cerulenin; epoxide; fatty-acid synthase; inhibitor; Acrylamide; Epoxy compounds; Drugs; Design; Fatty acids; Inhibitors; Fatty acids; Synthesis; Antibiotics; Antifungal agents

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Doxsee, I. (2016). The design and synthesis of novel aromatic analogues of cerulenin. (Masters Thesis). Northeastern University. Retrieved from http://hdl.handle.net/2047/D20211286

Chicago Manual of Style (16th Edition):

Doxsee, Ian. “The design and synthesis of novel aromatic analogues of cerulenin.” 2016. Masters Thesis, Northeastern University. Accessed March 19, 2019. http://hdl.handle.net/2047/D20211286.

MLA Handbook (7th Edition):

Doxsee, Ian. “The design and synthesis of novel aromatic analogues of cerulenin.” 2016. Web. 19 Mar 2019.

Vancouver:

Doxsee I. The design and synthesis of novel aromatic analogues of cerulenin. [Internet] [Masters thesis]. Northeastern University; 2016. [cited 2019 Mar 19]. Available from: http://hdl.handle.net/2047/D20211286.

Council of Science Editors:

Doxsee I. The design and synthesis of novel aromatic analogues of cerulenin. [Masters Thesis]. Northeastern University; 2016. Available from: http://hdl.handle.net/2047/D20211286


Univerzitet u Beogradu

29. Čalija, Bojan R., 1982-. Funkcionalnost hitozana u formulaciji alginat-hitozan mikročestica kao nosača za nesteroidne antiinflamatorne lekove.

Degree: Farmaceutski fakultet, 2014, Univerzitet u Beogradu

Farmacija - Farmaceutska tehnologija / Pharmacy - Pharmaceutical technology

Prednosti mikročestica u odnosu na konvencionalne nosače lekovitih supstanci ogledaju se u sferičnom obliku, velikom odnosu… (more)

Subjects/Keywords: chitosan; chitosan oligosaccharide; sodium alginate; polyelectrolyte complex; microparticles; naproxen; nonsteroidal antiinflamatory drugs; sustained release; pH sensitivity; experimental design

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Čalija, Bojan R., 1. (2014). Funkcionalnost hitozana u formulaciji alginat-hitozan mikročestica kao nosača za nesteroidne antiinflamatorne lekove. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:7198/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Čalija, Bojan R., 1982-. “Funkcionalnost hitozana u formulaciji alginat-hitozan mikročestica kao nosača za nesteroidne antiinflamatorne lekove.” 2014. Thesis, Univerzitet u Beogradu. Accessed March 19, 2019. https://fedorabg.bg.ac.rs/fedora/get/o:7198/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Čalija, Bojan R., 1982-. “Funkcionalnost hitozana u formulaciji alginat-hitozan mikročestica kao nosača za nesteroidne antiinflamatorne lekove.” 2014. Web. 19 Mar 2019.

Vancouver:

Čalija, Bojan R. 1. Funkcionalnost hitozana u formulaciji alginat-hitozan mikročestica kao nosača za nesteroidne antiinflamatorne lekove. [Internet] [Thesis]. Univerzitet u Beogradu; 2014. [cited 2019 Mar 19]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:7198/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Čalija, Bojan R. 1. Funkcionalnost hitozana u formulaciji alginat-hitozan mikročestica kao nosača za nesteroidne antiinflamatorne lekove. [Thesis]. Univerzitet u Beogradu; 2014. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:7198/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Georgia Tech

30. O'Daniel, Peter Ivo. Exploring structural diversity in nucleoside and nucleic acid drug design.

Degree: PhD, Chemistry and Biochemistry, 2005, Georgia Tech

 The design and optimization of chemotherapeutic molecules through molecular modeling is a rapidly growing aspect of drug design. The recent increase in computer power and… (more)

Subjects/Keywords: DNA; Nucleosides; Nucleotides; Enzymes; Fleximers; Drugs Design

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

O'Daniel, P. I. (2005). Exploring structural diversity in nucleoside and nucleic acid drug design. (Doctoral Dissertation). Georgia Tech. Retrieved from http://hdl.handle.net/1853/14042

Chicago Manual of Style (16th Edition):

O'Daniel, Peter Ivo. “Exploring structural diversity in nucleoside and nucleic acid drug design.” 2005. Doctoral Dissertation, Georgia Tech. Accessed March 19, 2019. http://hdl.handle.net/1853/14042.

MLA Handbook (7th Edition):

O'Daniel, Peter Ivo. “Exploring structural diversity in nucleoside and nucleic acid drug design.” 2005. Web. 19 Mar 2019.

Vancouver:

O'Daniel PI. Exploring structural diversity in nucleoside and nucleic acid drug design. [Internet] [Doctoral dissertation]. Georgia Tech; 2005. [cited 2019 Mar 19]. Available from: http://hdl.handle.net/1853/14042.

Council of Science Editors:

O'Daniel PI. Exploring structural diversity in nucleoside and nucleic acid drug design. [Doctoral Dissertation]. Georgia Tech; 2005. Available from: http://hdl.handle.net/1853/14042

[1] [2] [3] [4]

.